首页 正文

Exploring barriers to clinical trial readiness among the myotonic dystrophy community: a mixed-methods study

{{output}}
Myotonic dystrophy (DM) is a multisystemic disorder characterized by significant heterogeneity in symptom manifestation, progression, and severity. This variability complicates clinical trial design and implementation, thereby affecting therapeutic development... ...